Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatment

被引:22
作者
Feely, N. M. [1 ]
Waghorn, D. J. [2 ]
Dexter, T. [1 ]
Gallen, I. [3 ]
Chiodini, P. [4 ]
机构
[1] Wycombe Gen Hosp, Dept Anaesthet, High Wycombe, Bucks, England
[2] Wycombe Gen Hosp, Dept Microbiol, High Wycombe, Bucks, England
[3] Wycombe Gen Hosp, Dept Gen Med, High Wycombe, Bucks, England
[4] Hosp Trop Dis, Dept Clin Parasitol, London NW1 0PE, England
关键词
IVERMECTIN;
D O I
10.1111/j.1365-2044.2009.06196.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Immunocompromised patients who are infected with Strongyloides stercoralis may develop a potentially fatal auto-infection syndrome characterised by non-specific pulmonary and gastrointestinal symptoms and Gram negative sepsis. We present the case of one such patient who underwent a negative laparotomy for a presumed intra-abdominal surgical catastrophe with a subsequent protracted stay on the intensive care unit. Once the diagnosis of strongyloidiasis was made, the patient was successfully treated with subcutaneous antihelminthic drugs. With appropriate screening for and eradication of strongyloides in those with immune compromise, or in those about to start immunosuppressive therapy, potentially fatal episodes of hyperinfection could be avoided. In the absence of screening, severe strongyloidiasis should be suspected in immunosuppressed individuals who have travelled to or resided in an endemic area and present with the characteristic features. Awareness of the signs of hyperinfection amongst those involved in acute care could prevent unnecessary morbidity and mortality in these patients.
引用
收藏
页码:298 / 301
页数:4
相关论文
共 10 条
[1]   Strongyloides stercoralis host-adapted third-stage larvae are the target of eosinophil-associated immune-mediated killing in mice [J].
Brigandi, RA ;
Rotman, HL ;
Leon, O ;
Nolan, TJ ;
Schad, GA ;
Abraham, D .
JOURNAL OF PARASITOLOGY, 1998, 84 (02) :440-445
[2]   Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis [J].
Carvalho, EM ;
Porto, AD .
PARASITE IMMUNOLOGY, 2004, 26 (11-12) :487-497
[3]   Parenteral ivermectin in Strongyloides hyperinfection [J].
Chiodini, PL ;
Reid, AJC ;
Wiselka, MJ ;
Firmin, R ;
Foweraker, J .
LANCET, 2000, 355 (9197) :43-44
[4]   A RANDOMIZED TRIAL OF SINGLE-DOSE AND 2-DOSE IVERMECTIN VERSUS THIABENDAZOLE FOR TREATMENT OF STRONGYLOIDIASIS [J].
GANN, PH ;
NEVA, FA ;
GAM, AA .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (05) :1076-1079
[5]   DYSREGULATION OF STRONGYLOIDIASIS - A NEW HYPOTHESIS [J].
GENTA, RM .
CLINICAL MICROBIOLOGY REVIEWS, 1992, 5 (04) :345-355
[6]   Strongyloides stercoralis in the immunocompromised population [J].
Keiser, PB ;
Nutman, TB .
CLINICAL MICROBIOLOGY REVIEWS, 2004, 17 (01) :208-+
[7]   Disseminated strongyloidiasis: a retrospective study of clinical course and outcome [J].
Lam, CS ;
Tong, MKH ;
Chan, KM ;
Siu, YP .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (01) :14-18
[8]  
PAKANOWSKI J, 2006, AM J TROP MED HYG, V73, P122
[9]   Clinical presentation and diagnostic sensitivity of laboratory tests for Strongyloides stercoralis in travellers compared with immigrants in a non-endemic country [J].
Sudarshi, S ;
Stümpfle, R ;
Armstrong, M ;
Ellman, T ;
Parton, S ;
Krishnan, P ;
Chiodini, PL ;
Whitty, CJM .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2003, 8 (08) :728-732
[10]   Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis [J].
Turner, SA ;
Maclean, JD ;
Fleckenstein, L ;
Greenaway, C .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (05) :911-914